Company / Total Debt
Altimmune, Inc. Total Debt History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$34.3M
FY2025
5-year range
$1.5M / $34.3M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt changed +648% YoY in FY2025, a notable deviation from the 4-year average annual change of +210%.
Based on SEC 10-K filings.
$34M in FY2025 with a 5-year CAGR of +79.7%.
Increased from $1M to $34M over the past 4 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- +95.6%
- 5-Year CAGR
- +79.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +79.7%, indicating consistent growth.
- Lowest total debt in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.3M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $4.6M | +215.0% |
| FY2021 | $1.5M | -20.5% |
| FY2020 | $1.8M | -2.0% |
| FY2019 | $1.9M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026